Overview

Study of Efficacy and Safety of Percutaneous Coronary Intervention to Improve Survival in Heart Failure

Status:
Active, not recruiting

Trial end date:
2022-04-01

Target enrollment:

Participant gender:

Summary

This study will assess whether percutaneous coronary intervention (angioplasty of the heart arteries) can improve survival and reduce hospitalization in patients with heart failure due to coronary disease, who have been treated with the best contemporary medical therapy.

Phase:

N/A

Details

Lead Sponsor:

King's College London

Collaborators:

Guy's and St Thomas' NHS Foundation Trust
London School of Hygiene and Tropical Medicine
London School of Hygiene and Tropical Medicine (Clinical Trials Unit)
National Institute for Health Research, United Kingdom
University of York